A growing body of research says yes, though not in the way most people picture it. The concern is not that a drug molecule hitches a ride inside a sperm cell and poisons the embryo directly. Instead, substances a father uses before conception can chemically reprogram his sperm’s epigenetic markers, and those altered markers can carry forward into a developing baby, influencing everything from growth to brain function. Most of the strongest evidence comes from animal studies, and translating those findings to humans is complicated by the messiness of real life. Still, the science has moved well past speculation.
How Sperm Carry More Than Just DNA
Sperm do not simply deliver a father’s genetic code and nothing else. They also carry a layer of chemical instructions layered on top of the DNA, often called the epigenome. These instructions include methyl groups attached to DNA and specific proteins called histones that help package the genome. During embryo development, certain histone profiles present in sperm are recapitulated in the embryo, meaning the packaging the father’s sperm brings to the table can shape how genes are read in the next generation.1PubMed Central. The Interplay Between Replacement and Retention of Histones in the Sperm Genome
When a father uses drugs, whether recreational, therapeutic, or occupational, those substances can alter this epigenetic layer. Research in animal models has documented changes to DNA methylation, histone modifications, and even the expression of small regulatory molecules called microRNAs in the sperm of drug-exposed males. Critically, some of these altered patterns have been found preserved in the brains of offspring, suggesting the changes are not just present at conception but persist as the baby develops.2PubMed Central. Who’s your daddy? Behavioral and epigenetic consequences of paternal drug exposure
Chemotherapy Drugs and DNA Damage
Cancer treatment is where the clearest and most alarming animal data exist. Cyclophosphamide, a widely used chemotherapy agent, has been studied extensively in rats. When male rats were chronically exposed to the drug and then bred, their offspring showed increased rates of implantation failure, miscarriage, and birth defects. The drug also dramatically suppressed stress-response genes in developing sperm cells, which may have allowed genetic damage to pile up unchecked.3JNCI Monographs. Impact of Paternal Exposure to Chemotherapy on Offspring in the Rat
Looking more closely at the fertilized embryos, researchers found that roughly two-thirds of embryos fathered by cyclophosphamide-exposed males showed detectable DNA damage at the single-cell stage, compared with fewer than one in five from unexposed fathers. The damaged embryos also showed altered activity in genes responsible for DNA repair, suggesting that the problem cascades: the sperm brings in broken DNA, and the embryo’s own repair machinery responds abnormally.4PubMed. Paternal exposure to cyclophosphamide induces DNA damage and alters the expression of DNA repair genes in the rat preimplantation embryo
The good news for human cancer survivors is that current clinical guidance already reflects this concern. Men undergoing chemotherapy or radiation are typically advised to wait at least three months after completing treatment before trying to conceive. That washout period allows the most damaged sperm to be cleared and replaced by cells that matured after exposure ended. The timing matters because the stage at which germ cells are first exposed influences how much damage accumulates: in the rat studies, longer treatment durations (nine weeks versus six) were required before chromosomal abnormalities like aneuploidy became detectable.3JNCI Monographs. Impact of Paternal Exposure to Chemotherapy on Offspring in the Rat
Alcohol Before Conception
Fetal alcohol spectrum disorders have long been linked almost exclusively to maternal drinking during pregnancy. That framing is shifting. Research now shows that a father’s alcohol use before conception can independently impair placental development and alter craniofacial patterning in offspring, with the severity increasing in a dose-dependent way. These findings come from controlled animal experiments where the mother was never exposed, isolating the father’s contribution.5Journal of Animal Science. 19 Paternal drinking and the epigenetic influences on mitochondrial function, placental dysfunction, and structural birth defects
The downstream effects appear to extend far beyond birth. Paternal alcohol exposure has been linked to lasting disruptions in mitochondrial function in the placenta and fetal brain. Those mitochondrial deficits persisted into adulthood in offspring, resulting in elevated oxidative stress, chronic inflammation, and signs of premature cellular aging in the brain and liver.5Journal of Animal Science. 19 Paternal drinking and the epigenetic influences on mitochondrial function, placental dysfunction, and structural birth defects Separate mouse studies have confirmed sex-specific patterns of fetal and postnatal growth restriction, along with long-term metabolic problems in the next generation, all traced to the father’s preconception drinking.6The FASEB Journal. Epigenetic Toxicity: Preconception Paternal Alcohol Exposure and the Programming of Offspring Birth Defects
These findings matter because alcohol use among prospective fathers rarely receives the same clinical scrutiny as maternal drinking. The research suggests that even if the mother avoids alcohol entirely during pregnancy, the father’s drinking habits in the months before conception may still leave a mark.
Cannabis and THC
Cannabis is the substance where public awareness lags furthest behind the emerging science. In both human sperm samples and rat models, THC exposure has been associated with widespread changes in DNA methylation at a gene called DLGAP2, which is an autism candidate gene. In exposed rats, several sites on DLGAP2 were significantly less methylated in sperm, and at least one of those same changes was detectable in the nucleus accumbens of the offspring’s brain, suggesting the altered pattern was transmitted from father to child.7PubMed Central. Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm
This is a single gene in a single pathway, and it would be premature to say that paternal cannabis use causes autism. But the finding that a drug-induced methylation change in sperm can be detected in specific brain regions of the next generation is significant. Reviews of the broader literature have urged attention to the long-term epigenetic risks for both the reproductive health of cannabis users and the health of their children.8PubMed Central. Cannabis and Paternal Epigenetic Inheritance
Given that cannabis use is rising in men of reproductive age across many countries, this is an area where the science is likely to develop quickly. For now, nobody can quantify a specific risk, but the biological plausibility for paternal effects is real.
Opioids
Opioid exposure affects sperm at multiple levels. Beyond the well-known hormonal disruptions (opioids suppress testosterone and can impair sperm production), there is evidence that opioid use alters germline epigenetic programming in ways that influence embryo development and the developmental trajectory of offspring. Both clinical observations and animal studies have documented effects on the behavior, physiology, and health of children born to opioid-exposed fathers.9PubMed Central. Consequences of Parental Opioid Exposure on Neurophysiology, Behavior, and Health in the Next Generations
Animal models of paternal opioid exposure have shown offspring with deficits in cognitive and emotional functioning, alongside measurable changes in brain chemistry. The epigenetic changes in sperm included altered methylation of imprinted genes and modifications to signaling pathways involved in learning and neural growth.2PubMed Central. Who’s your daddy? Behavioral and epigenetic consequences of paternal drug exposure This is concerning given the scale of opioid use, but as with other substances, the jump from animal models to firm human predictions remains large.
Prescription Medications That Have Been Studied
Not every drug a father takes poses the same level of concern. For several commonly prescribed medication classes, the evidence is more reassuring than alarming.
Methotrexate, used for autoimmune conditions like rheumatoid arthritis and psoriasis, has long worried patients and doctors because of its known risks when taken by pregnant women. But a recent systematic review and meta-analysis found no increased risk of birth defects, stillbirth, or preterm birth when fathers were the ones taking the drug around the time of conception. No consistent pattern of malformations turned up in case reports, either.10PubMed. Pregnancy Outcomes Following Paternal Methotrexate Exposure: A Systematic Review and Meta-Analysis
Antidepressants, particularly SSRIs, have also been investigated. A large Swedish population study found that paternal antidepressant use around the time of conception was not associated with preterm birth, birth defects, autism, or intellectual disability in offspring.11PubMed Central. Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study A separate population-based study did find a mildly elevated rate of autism in children whose fathers used SSRIs before conception, but the researchers concluded that this was likely explained by the fathers’ underlying psychiatric conditions rather than the medication itself.12PubMed Central. Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study This is an important distinction: the condition being treated, not the treatment, appeared to be the relevant factor.
These findings should offer some comfort to men who need ongoing medication. Stopping a prescribed drug before conception can carry its own risks, particularly for mental health, and the data so far do not support doing so for the sake of the baby.
Anabolic Steroids
Anabolic steroid use sits in a different category because the drugs directly interfere with the hormonal signals that drive sperm production. In rat studies, the anabolic steroid trenbolone caused significant drops in testosterone, sperm count, sperm motility, and normal sperm shape, along with increased testicular DNA damage and markers of cell death.13PubMed Central. Therapeutic effects of vitamin B17 against anabolic steroid Trenorol induced testicular toxicity, injury, DNA damage and apoptosis in male rats The primary risk here is reduced fertility rather than birth defects, but the DNA damage observed in testicular tissue raises questions about the quality of any sperm that are produced.
Recovery after steroid cessation is variable. Some men regain normal sperm parameters within months; others take a year or longer, and a small percentage may not fully recover. For men using anabolic steroids who are planning a family, the clearest advice is to stop well in advance and have sperm quality assessed before attempting conception.
Seminal Fluid Is a Separate Pathway
Most of the research discussed above focuses on what happens inside the sperm cell. But sperm do not arrive alone. They travel in seminal fluid, and that fluid interacts with the mother’s reproductive tract in ways that can influence pregnancy outcomes independently.
Seminal plasma contains proteins, cytokines, and growth factors that help prepare the uterine lining for implantation and modulate the mother’s immune system to tolerate the embryo. Changes in the composition of seminal plasma can reduce its beneficial effects, potentially lowering fertility and increasing the risk of complications.14PubMed Central. The immunomodulatory role of seminal plasma in endometrial receptivity and embryo implantation
Despite this, there is remarkably little guidance on whether drugs present in seminal fluid at the time of intercourse could directly expose a pregnant partner to harmful amounts. One review noted the near-total absence of clinical guidelines addressing this route of exposure for women of childbearing potential.15PubMed Central. Clinical trial considerations on male contraception and collection of pregnancy information from female partners The amounts of most drugs that end up in seminal fluid are generally small, but for particularly toxic compounds like certain chemotherapy agents, barrier contraception during treatment is often recommended as a precaution.
Why Human Evidence Is Hard to Pin Down
If you are reading this thinking “the animal evidence sounds convincing, but what about humans?” you are asking the right question. The fundamental challenge is that in human pregnancies, you cannot isolate paternal drug exposure the way you can in a controlled mouse experiment. Mothers have their own exposures, medical conditions, and genetic contributions. Couples who share a household often share environmental exposures, diets, and stress levels.
Large pharmacovigilance databases like the FDA’s adverse event reporting system have been mined for signals of paternal drug effects, but these databases have significant blind spots. They rarely capture detailed information about the mother’s health, her own medications, or gestational timing. Researchers who have worked with these databases acknowledge that false-negative signals may be common, particularly for medications used infrequently, and that the inherent limitations of spontaneous reporting systems cannot be fully eliminated.16PubMed Central. Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
This means we are in a phase where the biological mechanisms are increasingly well understood, the animal evidence is consistent and concerning for several substance categories, but definitive human proof for most drugs remains elusive. That gap should not be confused with evidence of safety. It mostly reflects the difficulty of doing the studies.
Paternal Age Adds Another Layer
Drug exposure does not exist in a vacuum. A father’s age at conception independently affects the mutation load in his sperm, because sperm-producing cells divide continuously throughout life, accumulating copying errors with each division. Research on retinoblastoma, an eye cancer in children, found a significant trend toward elevated risk of new mutations in offspring as paternal age increased. Fathers under 25 had a markedly lower risk of transmitting de novo mutations compared with older fathers.17PubMed Central. Increasing Paternal Age Associated With Elevated Risk of De Novo Mutations in Offspring Diagnosed With Sporadic Bilateral Retinoblastoma
This matters for the drug question because older fathers who are also using medications or recreational substances may face compounding risks. The age-related mutation accumulation and the drug-related epigenetic changes are separate processes, but both affect the quality of what sperm deliver to the embryo. Men who are older and planning conception have more reason, not less, to pay attention to what they are putting in their bodies.
What This Means for IVF and Assisted Reproduction
Couples using in vitro fertilization might assume that because the process is so controlled, paternal exposures matter less. The opposite may be true. In a mouse model of IVF, paternal alcohol exposure reduced embryo survival and pregnancy success rates in a dose-dependent fashion, with the highest alcohol group seeing pregnancy rates drop to half of those in controls.18PubMed Central. Preconception paternal alcohol exposure decreases IVF embryo survival and pregnancy success rates in a mouse model
IVF already carries financial and emotional costs that make each cycle precious. If paternal substance use is quietly lowering the odds of success, that is information couples deserve to have. Fertility clinics routinely counsel women about lifestyle factors before a cycle, but equivalent attention to the male partner’s substance use is far less common.
GLP-1 Drugs and an Emerging Question
With millions of men now taking GLP-1 receptor agonists like semaglutide for weight loss and diabetes, questions about reproductive effects are inevitable. The early picture is actually somewhat positive: in obese men, these drugs appear to improve sperm metabolism, motility, and concentration, likely as a downstream benefit of weight loss itself.19PubMed Central. Impact of GLP-1 Agonists on Male Reproductive Health—A Narrative Review Obesity is itself a well-established threat to sperm quality, so a drug that reverses obesity may indirectly benefit reproductive outcomes.
That said, the data are still limited, and improvements in standard sperm parameters like count and motility do not tell us anything about epigenetic effects. Whether GLP-1 drugs alter sperm methylation patterns or other epigenetic markers has not been studied in a meaningful way yet. For now, men taking these medications and planning a pregnancy should not panic, but this is a space where the research simply has not caught up with usage.
Teratology Counseling and What Fathers Are Told
Historically, the entire field of birth defect prevention has focused on the mother. Teratology information services, which counsel patients about exposures during pregnancy, report that the vast majority of their paternal-exposure calls concern either prescription drugs or cancer treatment. The standard counseling message has been that, in humans, there is no firm evidence of birth defects from paternal exposures, but that men who have undergone chemotherapy or radiation should delay conception for at least three months after treatment ends.20PubMed Central. Paternal exposure and counselling: experience of a Teratology Information Service
That message is reasonable but increasingly incomplete. The three-month waiting period addresses direct DNA damage to sperm from cytotoxic drugs. It does not address the subtler epigenetic changes caused by chronic alcohol use, cannabis, opioids, or other substances, which may require a different timeline or approach entirely. As the science evolves, clinical recommendations will need to evolve with it. In the meantime, couples planning a pregnancy might consider the father’s substance use as part of the preconception conversation, not just the mother’s.